🇺🇸 Live attenuated Japanese encephalitis vaccine SA14-14-2 in United States

Live attenuated Japanese encephalitis vaccine SA14-14-2 (Live attenuated Japanese encephalitis vaccine SA14-14-2) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Live attenuated Japanese encephalitis vaccine SA14-14-2 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Live attenuated Japanese encephalitis vaccine SA14-14-2 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Live attenuated Japanese encephalitis vaccine SA14-14-2 in United States?

Indian Institute of Science is the originator. The local marketing authorisation holder may differ — check the official source linked above.